OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 73 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,346 | +12.1% | 51,526 | -18.0% | 0.00% | – |
| Q2 2023 | $567,599 | +43.6% | 62,857 | -44.8% | 0.00% | – |
| Q1 2023 | $395,198 | -20.5% | 113,890 | -43.9% | 0.00% | – |
| Q4 2022 | $497,159 | -37.3% | 202,922 | -29.4% | 0.00% | – |
| Q3 2022 | $793,000 | -55.3% | 287,504 | -34.1% | 0.00% | – |
| Q2 2022 | $1,776,000 | -31.1% | 436,432 | -27.9% | 0.00% | – |
| Q1 2022 | $2,579,000 | -53.5% | 605,260 | +2.2% | 0.00% | -100.0% |
| Q4 2021 | $5,544,000 | +133.6% | 592,325 | +587.8% | 0.00% | – |
| Q3 2021 | $2,373,000 | -32.2% | 86,124 | -31.2% | 0.00% | – |
| Q2 2021 | $3,501,000 | +71.6% | 125,160 | +103.7% | 0.00% | – |
| Q1 2021 | $2,040,000 | -7.3% | 61,458 | +34.3% | 0.00% | – |
| Q4 2020 | $2,201,000 | – | 45,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |